Results for
"[search-keyword]"
Sponsor content
6 result(s) found, displaying 1 to 6
-
Cancellation by sponsorRequested by ORSPEC Pharma Pty Ltd
-
Australian Public Assessment Report (AusPAR)New AusPAR for Ruzurgi (amifampridine) for the treatment of Lambert-Eaton myasthenic syndrome.
-
-
Prescription medicine registrationActive ingredients: amifampridine.
-
-